Literature DB >> 1975269

Acute neuropathological changes in the caudate nucleus caused by MPTP and methamphetamine: immunohistochemical studies.

A Hess1, C Desiderio, W G McAuliffe.   

Abstract

Three days after the administration of MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) or methamphetamine to mice, there is degeneration and disappearance of punctate tyrosine hydroxylase-containing synaptic endings in the caudate nucleus. The neuropil is occupied with longer, varicose, branching fibres, which appear to be preterminal fibres. An intense gliosis occurs. The sparsely-occurring glial cells, with profuse lightly-stained (by glial fibrillary acidic protein) processes which are primarily located near blood vessels, become transformed into more heavily-stained star-shaped cells with fewer but thicker processes. These cells are distributed throughout the caudate. Despite apparent differences in the mechanism by which MPTP and methamphetamine cause dopamine depletion, the neuropathological changes in the caudate induced by these substances are identical.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1975269     DOI: 10.1007/bf01188403

Source DB:  PubMed          Journal:  J Neurocytol        ISSN: 0300-4864


  15 in total

1.  Striatal responses to partial dopaminergic lesion: evidence for compensatory sprouting.

Authors:  D D Song; S N Haber
Journal:  J Neurosci       Date:  2000-07-01       Impact factor: 6.167

2.  Repeated co-administrations of alcohol- and methamphetamine-produced anxiogenic effect could be associated with the neurotoxicity in the dentate gyrus.

Authors:  Jia-Ying Chuang; Wan-Ting Chang; Chianfang G Cherng; Gour-Shenq Kao; Lung Yu
Journal:  J Neural Transm (Vienna)       Date:  2011-04-17       Impact factor: 3.575

3.  Increased Vesicular Monoamine Transporter 2 (VMAT2; Slc18a2) Protects against Methamphetamine Toxicity.

Authors:  Kelly M Lohr; Kristen A Stout; Amy R Dunn; Minzheng Wang; Ali Salahpour; Thomas S Guillot; Gary W Miller
Journal:  ACS Chem Neurosci       Date:  2015-03-09       Impact factor: 4.418

4.  Toxic effect of methamphetamine on the retina of CD1 mice.

Authors:  Hong Lai; Huiyang Zeng; Cheng Zhang; Lin Wang; Mark O M Tso; Shenghan Lai
Journal:  Curr Eye Res       Date:  2009-09       Impact factor: 2.424

Review 5.  The role of oxidative stress, metabolic compromise, and inflammation in neuronal injury produced by amphetamine-related drugs of abuse.

Authors:  Bryan K Yamamoto; Jamie Raudensky
Journal:  J Neuroimmune Pharmacol       Date:  2008-08-15       Impact factor: 4.147

6.  Adaptation of brain glutamate plus glutamine during abstinence from chronic methamphetamine use.

Authors:  Thomas Ernst; Linda Chang
Journal:  J Neuroimmune Pharmacol       Date:  2008-06-03       Impact factor: 4.147

7.  Reduced vesicular storage of dopamine exacerbates methamphetamine-induced neurodegeneration and astrogliosis.

Authors:  Thomas S Guillot; Kennie R Shepherd; Jason R Richardson; Min Z Wang; Yingjie Li; Piers C Emson; Gary W Miller
Journal:  J Neurochem       Date:  2008-07-15       Impact factor: 5.372

8.  Enhanced P2Y1 receptor expression in the brain after sensitisation with d-amphetamine.

Authors:  Heike Franke; Holger Kittner; Jens Grosche; Peter Illes
Journal:  Psychopharmacology (Berl)       Date:  2003-03-22       Impact factor: 4.530

Review 9.  Astroglial correlates of neuropsychiatric disease: From astrocytopathy to astrogliosis.

Authors:  Ronald Kim; Kati L Healey; Marian T Sepulveda-Orengo; Kathryn J Reissner
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2017-10-06       Impact factor: 5.067

10.  Gut and brain profiles that resemble pre-motor and early-stage Parkinson's disease in methamphetamine self-administering rats.

Authors:  Amanda L Persons; Brinda Desai Bradaric; Leo P Kelly; Sharanya M Kousik; Steven M Graves; Bryan K Yamamoto; T Celeste Napier
Journal:  Drug Alcohol Depend       Date:  2021-05-20       Impact factor: 4.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.